Medicines update
6th February 2014
The TGA has commenced a review of the safety of Protos following a decision by the European Medicines Agency's Pharmacovigilance Risk Assessment Committee to recommend cessation of its use to treat osteoporosis, while product information for quetiapine has been updated.
Protos review underway
The TGA is currently reviewing the safety of strontium ranelate (Protos)
In a release, the TGA